IDARUBICIN CONTAINING REGIMEN AND RHU-G-CSF ARE CAPABLE IN CML PATIENTS OF RECRUITING CD34+ DR CELLS WITH HIGH PROLIFERATIVE POTENTIAL AND SUSTAIN PH-NEGATIVE POLYCLONAL HEMATOPOIESIS/
Am. Carella et al., IDARUBICIN CONTAINING REGIMEN AND RHU-G-CSF ARE CAPABLE IN CML PATIENTS OF RECRUITING CD34+ DR CELLS WITH HIGH PROLIFERATIVE POTENTIAL AND SUSTAIN PH-NEGATIVE POLYCLONAL HEMATOPOIESIS/, Experimental hematology, 22(8), 1994, pp. 776-776